Reference
Ahmadzadehfar H, et al. Hematotoxicity and non-hematological adverse events of Ra-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and bone metastases. Journal of Nuclear Medicine 56 (Suppl. 3): [1 page] abstr. 1227, 1 May 2015. Available from: URL: http://jnm.snmjournals.org/content/56/supplement_3/1227.abstract?sid=e23f31b8-e38b-4082-ab3d-1fc6cb1194b7 - Germany
Rights and permissions
About this article
Cite this article
Radium 223 chloride. Reactions Weekly 1564, 178 (2015). https://doi.org/10.1007/s40278-015-4321-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-4321-4